Dr. Keith Vossel, Neurologist and Director of the Easton Center, was quoted in a San Francisco Chronicle July 7th article about more observations and real-world data needed to determine the effectiveness of the newly approved Alzheimer’s drug, Leqembi.
Read San Francisco Chronicle Article
